HUT50040A - Process for producing aqueous compositions comprising cyclopentyl heptenoic acid derivative - Google Patents
Process for producing aqueous compositions comprising cyclopentyl heptenoic acid derivativeInfo
- Publication number
- HUT50040A HUT50040A HU886537A HU653788A HUT50040A HU T50040 A HUT50040 A HU T50040A HU 886537 A HU886537 A HU 886537A HU 653788 A HU653788 A HU 653788A HU T50040 A HUT50040 A HU T50040A
- Authority
- HU
- Hungary
- Prior art keywords
- cyclopentyl
- acid derivative
- aqueous compositions
- heptenoic acid
- producing aqueous
- Prior art date
Links
- GXLHENQYFQFJGL-UHFFFAOYSA-N 2-cyclopentylhept-2-enoic acid Chemical class CCCCC=C(C(O)=O)C1CCCC1 GXLHENQYFQFJGL-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878729823A GB8729823D0 (en) | 1987-12-22 | 1987-12-22 | Complexes |
| GB888804422A GB8804422D0 (en) | 1988-02-25 | 1988-02-25 | Complexes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT50040A true HUT50040A (en) | 1989-12-28 |
| HU204700B HU204700B (en) | 1992-02-28 |
Family
ID=26293226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU886537A HU204700B (en) | 1987-12-22 | 1988-12-21 | Process for producing aqueous compositions comprising piperidinyl cyclopentylheptenoic acid derivatives |
Country Status (29)
| Country | Link |
|---|---|
| JP (1) | JPH02210A (hu) |
| KR (1) | KR890009402A (hu) |
| CN (1) | CN1034132A (hu) |
| AT (1) | AT395943B (hu) |
| AU (1) | AU615245B2 (hu) |
| BE (1) | BE1001704A3 (hu) |
| CA (1) | CA1328078C (hu) |
| CH (1) | CH676665A5 (hu) |
| DE (1) | DE3843059A1 (hu) |
| DK (1) | DK712888A (hu) |
| ES (1) | ES2011727A6 (hu) |
| FI (1) | FI885920A (hu) |
| FR (1) | FR2624731B1 (hu) |
| GB (1) | GB2211737B (hu) |
| GR (1) | GR880100854A (hu) |
| HU (1) | HU204700B (hu) |
| IE (1) | IE61995B1 (hu) |
| IL (1) | IL88764A0 (hu) |
| IT (1) | IT1224835B (hu) |
| LU (1) | LU87411A1 (hu) |
| MY (1) | MY103952A (hu) |
| NL (1) | NL8803126A (hu) |
| NO (1) | NO885689L (hu) |
| NZ (1) | NZ227446A (hu) |
| PH (1) | PH24982A (hu) |
| PL (1) | PL276595A1 (hu) |
| PT (1) | PT89301B (hu) |
| SE (1) | SE502288C2 (hu) |
| ZW (1) | ZW18088A1 (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814725D0 (en) * | 1988-06-21 | 1988-07-27 | Glaxo Group Ltd | Medicaments |
| AU616571B2 (en) * | 1988-10-28 | 1991-10-31 | Shiseido Company Ltd. | Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin |
| IT1269578B (it) * | 1994-04-22 | 1997-04-08 | Chiesi Farma Spa | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. |
| KR100825736B1 (ko) * | 2005-12-07 | 2008-04-29 | 한국전자통신연구원 | 무선 ｘｍｌ 전자 서명 서비스 제공 장치 및 그 방법 |
| KR100832740B1 (ko) * | 2007-01-17 | 2008-05-27 | 한국과학기술원 | 분지쇄 아미노산 생성능이 개선된 변이 미생물 및 이를이용한 분지쇄 아미노산의 제조방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS503362B1 (hu) * | 1970-06-10 | 1975-02-04 | ||
| JPS5443569B2 (hu) * | 1972-07-05 | 1979-12-20 | ||
| HU181703B (en) * | 1980-05-09 | 1983-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents |
| JPS57183772A (en) * | 1981-04-29 | 1982-11-12 | Glaxo Group Ltd | Aminocyclopentanol acids and esters, manufacture and medicinal composition |
| JPS58116423A (ja) * | 1981-12-28 | 1983-07-11 | Sumitomo Chem Co Ltd | メタノプロスタサイクリン製剤組成物 |
| JPS58192821A (ja) * | 1982-04-30 | 1983-11-10 | Dainippon Pharmaceut Co Ltd | 脳神経細胞の酸素欠乏性疾患の治療剤 |
| JPS5946228A (ja) * | 1982-09-08 | 1984-03-15 | Zeria Shinyaku Kogyo Kk | 生物学的に活性な有機化合物の水溶性及びリンパ移行性薬剤の製造方法 |
| GB2127406B (en) * | 1982-09-16 | 1986-03-05 | Glaxo Group Ltd | Piperidinlycyclopentanolheptenoic acid salt |
| JPS5973576A (ja) * | 1982-09-16 | 1984-04-25 | グラクソ・グル−プ・リミテツド | ピペリジニルシクロペンタノ−ルヘプテン酸塩 |
| DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
| JPS60150039A (ja) * | 1984-01-17 | 1985-08-07 | Minolta Camera Co Ltd | 水陸両用固定焦点カメラ |
| DE3504044A1 (de) * | 1985-02-04 | 1986-08-07 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel |
| JPS6327440A (ja) * | 1986-07-18 | 1988-02-05 | Sanraku Inc | グルコシル化分岐シクロデキストリン含有組成物 |
-
1988
- 1988-12-21 BE BE8801423A patent/BE1001704A3/fr not_active IP Right Cessation
- 1988-12-21 FI FI885920A patent/FI885920A/fi not_active Application Discontinuation
- 1988-12-21 PT PT89301A patent/PT89301B/pt not_active IP Right Cessation
- 1988-12-21 AT AT0313088A patent/AT395943B/de not_active IP Right Cessation
- 1988-12-21 GR GR880100854A patent/GR880100854A/el unknown
- 1988-12-21 SE SE8804607A patent/SE502288C2/sv not_active IP Right Cessation
- 1988-12-21 CA CA000586606A patent/CA1328078C/en not_active Expired - Fee Related
- 1988-12-21 NZ NZ227446A patent/NZ227446A/xx unknown
- 1988-12-21 ZW ZW180/88A patent/ZW18088A1/xx unknown
- 1988-12-21 AU AU27356/88A patent/AU615245B2/en not_active Ceased
- 1988-12-21 CN CN88108916A patent/CN1034132A/zh active Pending
- 1988-12-21 NL NL8803126A patent/NL8803126A/nl not_active Application Discontinuation
- 1988-12-21 NO NO88885689A patent/NO885689L/no unknown
- 1988-12-21 LU LU87411A patent/LU87411A1/fr unknown
- 1988-12-21 HU HU886537A patent/HU204700B/hu not_active IP Right Cessation
- 1988-12-21 KR KR1019880017106A patent/KR890009402A/ko not_active Application Discontinuation
- 1988-12-21 GB GB8829793A patent/GB2211737B/en not_active Expired - Fee Related
- 1988-12-21 JP JP63320759A patent/JPH02210A/ja active Pending
- 1988-12-21 ES ES8803876A patent/ES2011727A6/es not_active Expired - Fee Related
- 1988-12-21 CH CH4758/88A patent/CH676665A5/de not_active IP Right Cessation
- 1988-12-21 DK DK712888A patent/DK712888A/da not_active Application Discontinuation
- 1988-12-21 IE IE382088A patent/IE61995B1/en not_active IP Right Cessation
- 1988-12-21 IT IT8848702A patent/IT1224835B/it active
- 1988-12-21 DE DE3843059A patent/DE3843059A1/de not_active Ceased
- 1988-12-21 FR FR8816902A patent/FR2624731B1/fr not_active Expired - Fee Related
- 1988-12-21 PH PH37963A patent/PH24982A/en unknown
- 1988-12-21 PL PL27659588A patent/PL276595A1/xx unknown
- 1988-12-22 IL IL88764A patent/IL88764A0/xx not_active IP Right Cessation
- 1988-12-22 MY MYPI88001508A patent/MY103952A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT37149A (en) | Process for producing quinoline- and naphtiridine-carboxylic acid derivatives | |
| HUT47138A (en) | Process for producing hyaluronic acid derivatives | |
| HUT36129A (en) | Process for producing //carboxy-alkenoyl/-amino/-cepheme-carboxylic acid derivatives | |
| YU135488A (en) | Process for producing benzamide derivative | |
| HUT37604A (en) | Process for producing 4-substituted-piperazine-2-carboxylic acids | |
| HUT34499A (en) | Process for producing cepheme-carboxylic acid derivatives | |
| EP0282989A3 (en) | Process for producing 5'-inosinic acid | |
| HUT46021A (en) | Process for producing ceph-3-eme-4-carboxylic acid derivatives | |
| IL86475A0 (en) | Process for producing phosphinyl-amino acid derivatives | |
| HUT50040A (en) | Process for producing aqueous compositions comprising cyclopentyl heptenoic acid derivative | |
| HUT49361A (en) | Process for producing piperazinecarboxylic acid derivative and pharmaceutical compositions comprising this compound | |
| HUT48632A (en) | Process for producing phosphinic acid derivatives | |
| GB2199030B (en) | Process for preparing alpha-phenylpropionic acid derivative | |
| HUT34201A (en) | Process for producing 2-substituted-2-peneme-3-carboxylic acid derivatives | |
| HUT38912A (en) | Process for producing quinolon- and naphtiridon-carboxylic acid derivatives | |
| HUT53868A (en) | Process for producing new aryl- or heteroaryl-1-alkyl-pirrol-2-carboxylic acid derivatives | |
| HUT38357A (en) | Process for producing a cepheme-carboxylic acid derivative /cephtazidim/ | |
| HUT40083A (en) | Process for producing quinolon-carboxylic acid derivatives | |
| HU906329D0 (en) | Process for producing pyridyl-cyclopropane-carboxylic acid derivatives | |
| DE3561316D1 (en) | Process for producing acetic acid | |
| HUT49324A (en) | Process for producing 2-oximino-3-oxo-butiric acid derivatives | |
| HUT46656A (en) | Process for producing aryl-amino-sulfonic acids | |
| HUT35688A (en) | Process for producing 3-azido-3-cepheme-4-karboxylic acid derivatives | |
| HUT48603A (en) | Process for producing 1-arylpyrazole-3-carboxylic acid ester derivatives | |
| EP0230895A3 (en) | Process for producing hydroxylamine-0-sulfonic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |